Arcus Biosciences, Inc.

NYSE:RCUS

Biotechnology

Healthcare
$15.78 -0.39%

-$0.09 today

Market cap
$2.27B
Beta
0.84
P/E (TTM)
-8.2
EPS (TTM)
-$2.94
52W Low $7.91High $28.72

Volume 1.07M

Average 1.17M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.14B

FY 2025 · Annual

-1.0% YoY

Liabilities

$508.00M

FY 2025 · Annual

-23.6% YoY

Equity

$631.00M

FY 2025 · Annual

+30.1% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents147.91M206M127M150M222M
Short-term Investments351.39M803M632M828M759M
Net Receivables746.82M43M42M25M16M
Inventory00000
Other Current Assets14.72M14M30M13M10M
Total Current Assets1.26B1.07B831M1.02B1.01B
Property, Plant & Equipment (Net)137.42M135M51M47M40M
Goodwill00000
Intangible Assets00000
Long-term Investments185M134M107M14M29M
Tax Assets00000
Other Non-current Assets7.73M10M106M73M63M
Total Non-current Assets330.15M279M264M134M132M
Total Assets1.59B1.35B1.1B1.15B1.14B
Account Payables10.26M20M17M18M42M
Short-term Debt5.1M3M000
Tax Payables1.82M001M0
Deferred Revenue102M97M91M85M35M
Other Current Liabilities30.26M48M39M14M18M
Total Current Liabilities166.08M193M184M226M231M
Long-term Debt00048M99M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)462.22M355M307M234M43M
Other Non-current Liabilities5.26M23M142M157M135M
Total Non-current Liabilities584.36M495M449M439M277M
Total Liabilities750.45M688M633M665M508M
Common Stock7K1.21B1.31B1.62B2.12B
Retained Earnings(275.35M)(542M)(849M)(1.13B)(1.49B)
Accumulated OCI(1.26M)(7M)000
Other Stockholders Equity00000
Minority Interest00000
Total Equity841.45M657M462M485M631M
Total Debt121.99M120M11M60M112M
Net Debt(25.93M)(86M)(116M)(90M)(110M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$150.0M
Short-term Investments$552.0M
Receivables$36.0M
Other Current$18.0M
Total Current Assets$756.0M
PP&E (Net)$36.0M
Long-term Investments$73.0M
Other Non-current$59.0M
Total Non-current Assets$168.0M
Total Assets$924.0M

Analysis

Selected assets total $924.0M for Latest. The largest visible component is Short-term Investments at $552.0M, about 59.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026
8-KCurrent reportOct 23, 2026
424B5424B5 filingOct 22, 2026
8-KCurrent reportOct 21, 2026

How much cash does RCUS have?

Arcus Biosciences, Inc. (RCUS) reported $222.00M in cash and equivalents in fiscal 2025.

How much debt does RCUS carry?

Arcus Biosciences, Inc. (RCUS) reported $112.00M of total debt, with net debt of -$110.00M.